Online monitoring and stable isotope tracing of cancer associated volatiles in murine model captures tumor associated markers in vivo
- Fouad Choueiry 1, Rui Xu 2, Andrew Gold 2, Hyein Jung 2, Jiangjiang Zhu 1
- Fouad Choueiry 1, Rui Xu 2, Andrew Gold 2
- 1Department of Human Sciences, The Ohio State University, USA; James Comprehensive Cancer Center, The Ohio State University, Columbus, OH, 43210, USA.
- 2Department of Human Sciences, The Ohio State University, USA.
- 0Department of Human Sciences, The Ohio State University, USA; James Comprehensive Cancer Center, The Ohio State University, Columbus, OH, 43210, USA.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Early lung cancer detection is challenging. This study used SESI-HRMS to identify volatile biomarkers in a mouse model, revealing metabolic pathways and treatment responses for improved diagnostics.
Area Of Science
- Biochemistry
- Analytical Chemistry
- Oncology
Background
- Early cancer detection significantly improves survival rates but lacks reliable diagnostic technologies and biomarkers.
- The tumor microenvironment alters host metabolism, influencing volatile compound synthesis, yet unique markers remain elusive due to metabolic heterogeneity and analytical standardization issues.
Purpose Of The Study
- To develop and validate a non-invasive screening platform for real-time monitoring of lung cancer volatiles.
- To identify specific volatile metabolites associated with lung cancer onset, progression, and treatment response.
Main Methods
- Utilized secondary electrospray ionization (SESI) coupled with high-resolution mass spectrometry (HRMS) for real-time volatile analysis.
- Employed a pre-clinical mouse model to study lung cancer development and response to chemotherapy.
Main Results
- Identified 651 dysregulated volatile features at cancer onset and 36 correlated with tumor size.
- Revealed the gamma-glutamyl cycle, linked to glutathione metabolism and reactive oxygen species (ROS), as a key pathway in lung cancer.
- Detected unique volatile changes with gemcitabine and cisplatin treatment, identifying 5-oxoproline as a marker for treatment response.
Conclusions
- SESI-HRMS provides a novel, non-invasive platform for sensitive, real-time detection and monitoring of lung cancer.
- The study elucidates volatile signatures linked to lung cancer metabolism and treatment efficacy.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.

